참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Water | HCID 962 | — |
| 반응물 | Benzothiazole | HCID 7222 | — |
| 반응물 | Butyllithium | HCID 178418339 | — |
| 반응물 | HCID 178502731 | HCID 178502731 | — |
| 용매 | Tetrahydrofuran | HCID 8028 | — |
| 생성물 | [4-(Benzothiazole-2-carbonyl)-cyclohexyl]-carbamic acid tert-butyl ester | HCID 67317166 | 82.1% |
반응 단계
To a solution of benzothiazole (675 mg, 0.55 ml, 5 mmol) in THF (20 ml) at −78° C. was added dropwise n-BuLi (2.5M in Hex, 2 ml) such that the temperature did not exceed −70° C. The brown solution was stirred at this temperature for 15 min before dropwise addition of a solution of [trans-4-(methoxy-methyl-carbamoyl)-cyclohexyl]-carbamic acid tert-butyl ester (716 mg, 2.5 mmol, prepared according to WO 03/053933) in THF (2 ml). The temperature was kept below −70° C. The brown solution was then gradually allowed to reach RT (over 3 h). Mixture was poured into water and extracted with EtOAc. The combined organic extracts were washed with brine and dried over MgSO4 and concentrated under reduced pressure. The residue was purified by chromatography over SiO2 (Hex/EtOAc 4:1 then DCM). The relevant fractions were pooled, evaporated under reduced pressure, digested with Hex and filtered to give 740 mg (82%) of [4-(benzothiazole-2-carbonyl)-cyclohexyl]-carbamic acid tert-butyl ester.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US07981886B2 |
|---|
| 출처 데이터셋 | uspto-grants-2011_07 |
|---|
| ORD ID | ord-35a01e6be0c24725a8d37793c2468181 |
|---|
| 출처 메모 | uspto-grants-2011_07 |
|---|